Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of disease.

Saved in:
Bibliographic Details
Title: Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of disease.
Authors: Moulder R; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland. robmou@utu.fi.; InFLAMES Research Flagship Centre, University of Turku, Turku, Finland. robmou@utu.fi., Hirvonen MK; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.; InFLAMES Research Flagship Centre, University of Turku, Turku, Finland., Välikangas T; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.; InFLAMES Research Flagship Centre, University of Turku, Turku, Finland., Suomi T; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.; InFLAMES Research Flagship Centre, University of Turku, Turku, Finland., Overbergh L; Katholieke Universiteit Leuven/Universitaire Ziekenhuizen, Leuven, Belgium., Peakman M; Immunology & Inflammation Research Therapeutic Area, Sanofi, Cambridge, UK., Brunak S; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Mathieu C; Katholieke Universiteit Leuven/Universitaire Ziekenhuizen, Leuven, Belgium., Knip M; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Pediatric Research Centre, New Children's Hospital, Helsinki University Hospital, Helsinki, Finland.; Department of Pediatrics, Tampere University Hospital, Tampere, Finland., Elo LL; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland. laura.elo@utu.fi.; InFLAMES Research Flagship Centre, University of Turku, Turku, Finland. laura.elo@utu.fi.; Institute of Biomedicine, University of Turku, Turku, Finland. laura.elo@utu.fi., Lahesmaa R; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland. rilahes@utu.fi.; InFLAMES Research Flagship Centre, University of Turku, Turku, Finland. rilahes@utu.fi.; Institute of Biomedicine, University of Turku, Turku, Finland. rilahes@utu.fi.
Corporate Authors: INNODIA consortium
Source: Diabetologia [Diabetologia] 2025 Jun; Vol. 68 (6), pp. 1108-1114. Date of Electronic Publication: 2025 Feb 28.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-0428
DOI:10.1007/s00125-025-06394-7